What’s happening at 10x Genomics, Inc. (NasdaqGS:TXG)? What made the stock one of the top performing stock today? The company is indeed among the top gainers of the stock market, skyrocketing 12.40% (or 7.69 points) to $69.71 from its previous close of $62.02. So is it the right moment to buy?
The shares had an increased trading volume of 363,986 contracts this session compared to the average daily volume of last 10 days of 215,862 contracts and they had an increased trading volume compared to the average daily volume of last 3 months of 223,898 contracts.
The indicator of a company’s profitability, the earnings per share ratio is -5.41. This value shows how much money a company makes for each share of its stock. A higher EPS indicates more value because investors will pay more for a company with higher profits. This is negative and tells you exactly how much money the company lost per share of its 20.9M outstanding stock.
The closing market price for this trading session was 54.53% over 52 weeks minimum price of $45.11 and 3.15% under 52 weeks maximum price of $71.98. Also the price is 21.23% greater than 200 day average of $57.50 and 12.61% greater than 50 day average of $61.91.
Latest news that might have contributed to the great perfomance of TXG today are:
- 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution, published on Tue, 26 Nov 2019 14:00:10 +0000
- 10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance, published on Thu, 07 Nov 2019 21:03:00 +0000
- 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019, published on Fri, 25 Oct 2019 20:45:05 +0000